Optimal upper respiratory tract sampling time for novel coronavirus pneumonia suspects
Zhou, J.; Chen, L.; Zhang, D.; Chen, H.; Sheng, Q.; Deng, H.; Zhang, Y.; Ni, S.; Luo, S.; Ren, B.
Show abstract
ObjectiveExplore best upper respiratory tract sampling time of suspected novel coronavirus pneumonia cases. MethodsWe collected dates of patients from Hangzhou, Shenzhen, Jinhua city and so on who had the clear exposure history of a novel coronavirus pneumonia(COVID-19). We retrospected demographic data, exposure time, onset time, visiting time and positive time for novel coronavirus nucleic acid detection in respiratory specimens. There were 256 patients from January 20,2020-February 12,2020 from eight cities included in our study. 106 cases appeared symptoms before January 25th and 150 after. ResultsThere were 136(53.1%)male infected cases. The mean age of all patients was 43.80{+/-}14.85. The median time from exposure to onset was 5(3,8) days. The median time of the first time of positive nucleic acid detection was 11(9,14)days and mode number was 13. The median time from onset to the first time of positive nucleic acid detection was 6(4,8)days and mode number was 5. The time from onset to definite diagnosis was 5(3,7) days before January 25th while it was 7.5(5,10)days after which was significantly shorter before January 25th(U=3885.5,P<0.001). The time from exposure to definite diagnosis was 11(9,14)days and 11(9,14)days before January 25th and after and without significant difference. The time from exposure to definite diagnosis was 11(9,13)days in first-tier cities and 13(11,15)days in second and third-tier cities. The difference was significantly shorter of first-tier cities(U=1355.5, P=0.039). And also the time was short from visiting to definite diagnosis which was 2(2,3)days in first-tier cities and 3(2,4)days in second and third-tier cities but without significant difference(U=842.5, P=0.054). ConclusionsFrom our study we found that the best upper respiratory tract sampling time for novel coronavirus pneumonia suspects was 13days after exposure. The time from onset to definite diagnosis was shorter after January 25th. The patients were diagnosed faster in the first-tier cities after exposure.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Survival analysis of hospital length of stay of novel coronavirus (COVID-19) pneumonia patients in Sichuan, China 96%
- dbGSRV: a manually curated database of genetic susceptibility to respiratory virus 94%
- SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts 94%
Similar papers in this journal
- Evaluation of the disease outcome in Covid-19 infected patients by disease symptoms: a retrospective cross-sectional study in Ilam Province, Iran 94%
- Explanation of Hand, Foot, and Mouth Disease Cases in Japan Using Google Trends Before and During the COVID-19: Infodemiology Study 93%
- Divergences on expected pneumonia cases during the COVID-19 epidemic in Catalonia: A time-series analysis of primary care electronic health records covering about 6 million people 93%
Similar papers in this journal
- Live poultry feeding and trading network and the transmission of avian influenza A(H5N6) virus in a large city in China, 2014-2015 95%
- Clinical characteristics of 25 death cases infected with COVID-19 pneumonia: a retrospective review of medical records in a single medical center, Wuhan, China 94%
- Ascertainment rate of novel coronavirus disease (COVID-19) in Japan 94%
Similar papers in this journal
- The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infection 93%
- SARS-CoV-2 seroprevalence among healthcare workers in general hospitals and clinics in Japan 92%
- Studies of Novel Coronavirus Disease 19 (COVID-19) Pandemic: A Global Analysis of Literature 92%
Similar papers in this journal
- Relative expression of pro-inflammatory molecules in COVID-19 patients manifested disease severities 94%
- Comprehensive genomic, immunological and clinical analysis of COVID-19 vaccine breakthrough infections: a prospective, comparative cohort study 94%
- Evaluation of rapid antibody test and chest computed tomography results of COVID-19 patients: A retrospective study 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.